Market share liability is a legal concept that requires companies to assume liability for a product irrespective of actual production, divided by their market shares.
The Orphan Drug Credit is a U.S. tax incentive designed to help pharmaceutical companies manage the high costs associated with developing drugs and treatments for exceedingly rare diseases. This article explores its purpose, benefits, and implications.
Our mission is to empower you with the tools and knowledge you need to make informed decisions, understand intricate financial concepts, and stay ahead in an ever-evolving market.